Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 3Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Hemangiosarcoma 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Desmoid Tumors 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

nirogacestat 5Specimen Handling 3Cryosurgery 3X-Rays 2Phantoms, Imaging 2Nivolumab 2Magnetic Resonance Spectroscopy 2Blood Specimen Collection 2trifluridine tipiracil drug combination 1strattice 1Oxaliplatin 1Leucovorin 1Ipilimumab 1Imatinib Mesylate 1High-Intensity Focused Ultrasound Ablation 1Fluorouracil 1Embolization, Therapeutic 1Electrochemotherapy 1E-7386 1Doxorubicin 1Cyclophosphamide 1Cryotherapy 1CTLA-4 Antigen 1Bone Density 1Bleomycin 1Biopsy 1Bevacizumab 1Absorptiometry, Photon 1Abdominoplasty 14-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Desmoid Tumors × 4-hydroxy-N-desmethyltamoxifen × 1 year × Clear all
NCT01273168 2025-12-23

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
40 enrolled
BreastGynecologicSarcoma

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡